| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |